Epi4K: Gene discovery in 4,000 genomes
Open Access
- 29 May 2012
- Vol. 53 (8), 1457-1467
- https://doi.org/10.1111/j.1528-1167.2012.03511.x
Abstract
A major challenge in epilepsy research is to unravel the complex genetic mechanisms underlying both common and rare forms of epilepsy, as well as the genetic determinants of response to treatment. To accelerate progress in this area, the National Institute of Neurological Disorders and Stroke (NINDS) recently offered funding for the creation of a “Center without Walls” to focus on the genetics of human epilepsy. This article describes Epi4K, the collaborative study supported through this grant mechanism and having the aim of analyzing the genomes of a minimum 4,000 subjects with highly selected and well-characterized epilepsy.Keywords
This publication has 98 references indexed in Scilit:
- De Novo Pathogenic SCN8A Mutation Identified by Whole-Genome Sequencing of a Family Quartet Affected by Infantile Epileptic Encephalopathy and SUDEPAmerican Journal of Human Genetics, 2012
- Genetic and Biologic Classification of Infantile SpasmsPediatric Neurology, 2011
- Rare copy number variants are an important cause of epileptic encephalopathiesAnnals of Neurology, 2011
- Copy number variants and infantile spasms: evidence for abnormalities in ventral forebrain development and pathways of synaptic functionEuropean Journal of Human Genetics, 2011
- Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in EpilepsyCell, 2011
- A Mutation in the Golgi Qb-SNARE Gene GOSR2 Causes Progressive Myoclonus Epilepsy with Early AtaxiaAmerican Journal of Human Genetics, 2011
- A Focal Epilepsy and Intellectual Disability Syndrome Is Due to a Mutation in TBC1D24American Journal of Human Genetics, 2010
- Rare Deletions at 16p13.11 Predispose to a Diverse Spectrum of Sporadic Epilepsy SyndromesAmerican Journal of Human Genetics, 2010
- Phenotypic concordance in 70 families with IGE-implications for genetic studies of epilepsyEpilepsy Research, 2008
- The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trialThe Lancet, 2007